Untargeted Metabolite Profiling Reveals Acute Toxicity of Pentosidine on Adipose Tissue of Rats DOI Creative Commons
Chuanqin Hu,

Zhenzhen Shao,

Wei Wu

и другие.

Metabolites, Год журнала: 2024, Номер 14(10), С. 539 - 539

Опубликована: Окт. 9, 2024

: Pentosidine is an advanced glycation end product that commonly found in heat-processed foods. has been involved the occurrence and development of some chronic diseases. It was reported pentosidine exposure can impair function liver kidneys. Adipose tissue, as active endocrine organ, plays important role maintaining normal physiological cells. However, metabolic mechanism causes to induce toxicity adipose tissue remains unclear.

Язык: Английский

Integrative Metabolism in MASLD and MASH: Pathophysiology and Emerging Mechanisms DOI Creative Commons
Gregory R. Steinberg, Celina M Valvano, William De Nardo

и другие.

Journal of Hepatology, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

The liver acts as a central metabolic hub, integrating signals from the gastrointestinal tract and adipose tissue to regulate carbohydrate, lipid, amino acid metabolism. Gut-derived metabolites, such acetate ethanol non-esterified fatty acids white (WAT), influence hepatic processes, which rely on mitochondrial function maintain systemic energy balance. Metabolic dysregulation obesity, insulin resistance, type 2 diabetes disrupt these pathways, leading dysfunction-associated steatotic disease (MASLD) steatohepatitis (MASH). This review explores fluxes within gut-adipose tissue-liver axis, focusing pivotal role of de novo lipogenesis (DNL), dietary substrates like glucose fructose, changes in during MASLD progression. It highlights contributions resistance impaired dynamics lipid accumulation. Further understanding how interplay between substrate flux gastro-intestinal integrates with intersects structural functional alterations mitochondria will be important identify novel therapeutic targets advance treatment MASH.

Язык: Английский

Процитировано

1

Associations of muscle mass, strength, and quality with diabetes and the mediating role of inflammation in two National surveys from China and the United states DOI
Zhiming Lu,

Yaoda Hu,

Huijing He

и другие.

Diabetes Research and Clinical Practice, Год журнала: 2024, Номер 214, С. 111783 - 111783

Опубликована: Июль 11, 2024

Язык: Английский

Процитировано

5

Research Progress on the Effect and Mechanism of Exercise Intervention on Sarcopenia Obesity DOI Creative Commons
Jun Chen,

Shaohui Jia,

Chenggen Guo

и другие.

Clinical Interventions in Aging, Год журнала: 2024, Номер Volume 19, С. 1407 - 1422

Опубликована: Авг. 1, 2024

With the increasingly severe situation of obesity and population aging, there is growing concern about sarcopenia (SO). SO refers to coexistence sarcopenia, which imposes a heavier burden on individuals society compared or alone. Therefore, comprehending pathogenesis implementing effective clinical interventions are vital for its prevention treatment. This review uses comprehensive literature search analysis PubMed, Web Science, CNKI databases, with terms including "Sarcopenic obesity", "exercise", "cytokines", "inflammation", "mitochondrial quality control", "microRNA", covering relevant studies published up July 2024. The results indicate that complex, involving mechanisms like age-related changes in body composition, hormonal alterations, inflammation, mitochondrial dysfunction, genetic epigenetic factors. Regarding exercise SO, aerobic can reduce fat mass, resistance increase skeletal muscle mass strength, combined achieve both, making it optimal intervention SO. potential by may prevent treat include regulating cytokine secretion, inhibiting inflammatory pathways, improving quality, mediating microRNA expression. emphasizes effectiveness mitigating sarcopenic through multifactorial mechanistic insights into exercise's therapeutic effects. Understanding these informs targeted strategies aimed at alleviating societal individual burdens associated

Язык: Английский

Процитировано

5

Curcumin inhibits pancreatic steatosis in mice with high fat diet through YAP/P53 pathway and confirmed through ultrasonic imaging DOI

Helin Ke,

Ziwei Xu,

Lina Han

и другие.

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, Год журнала: 2025, Номер unknown, С. 159605 - 159605

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Puerarin improves MASLD by remodeling intestinal microenvironment to promote mitochondrial fusion and autophagy DOI Creative Commons

Chunbin Sun,

Mei Du,

Sha Sh

и другие.

Journal of Pharmacological Sciences, Год журнала: 2025, Номер 158(1), С. 27 - 41

Опубликована: Март 4, 2025

Pueraria Mirifica (Willd. Ohwi) is a medicine with anti-inflammatory and lipid-lowering properties. Puerarin one of the main active components Pueraria. The aim this study was to investigate possible mechanisms in treatment non-alcoholic fatty liver disease. therapeutic effect drug demonstrated by serum pathology indicators. mechanism action puerarin intestinal microbial changes short-chain acid content tests. alleviating Metabolic dysfunction-associated steatotic disease (MASLD) regulating flora predicted bioinformatics. relationship between revealed q-PCR detection mRNA expression level metabolic genes. And further verified clearance experiments. reduced vacuolar-like changes, lipid deposition, inflammatory cell infiltration livers high-fat diet (HFD) model mice. gut microbiota abundance diversity were remodeled, increased, mucosal barrier repaired, accompanied reduction cytokines. regulated hepatic metabolism genes alleviate MASLD. These results suggested that treats MASLD treating altering bacterial anti-inflammation.

Язык: Английский

Процитировано

0

Arsenic and metabolic diseases: New insights from mesenchymal stem cells DOI
Yuxin Hu, Jialin He, Yue Ma

и другие.

Toxicology and Applied Pharmacology, Год журнала: 2025, Номер unknown, С. 117299 - 117299

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss DOI
Kim Henriksen, Manu V. Chakravarthy, Cecilie Liv Bager

и другие.

Diabetes Obesity and Metabolism, Год журнала: 2025, Номер unknown

Опубликована: Апрель 10, 2025

Abstract Anti‐obesity medications have reached new heights in terms of efficacy, with presently available pharmacological options almost reaching the efficacy surgical techniques, and thus these are starting to fill treatment void. Because increased weight loss benefits on a host obesity complications being reported, prevention diabetes, reduction liver cardiovascular improvements osteoarthritis among prominent features. On other hand, present anti‐obesity strategies also lead lean bone mass, while consequences hereof only beginning present, they highly likely be importance target population that contains large number elderly potentially frail individuals. Therefore, there is need address issue quality, both context existing possibilities, but especially myriad novel horizon.

Язык: Английский

Процитировано

0

Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-γ agonist rosiglitazone as a browning reference drug DOI Creative Commons
Lorenzo Flori,

Giulia Galgani,

Giorgia Bray

и другие.

Frontiers in Pharmacology, Год журнала: 2025, Номер 16

Опубликована: Апрель 14, 2025

Background Obesity is a metabolic disease that characterized by an excessive accumulation of adipose tissue (AT) and often associated with other pathologies. AT lipid storage organ endocrine functions presents two main phenotypes: white (WAT) brown (BAT). Preadipocytes or mature adipocyte cells can differentiate in middle phenotype morpho/functional characteristics between WAT BAT, known as brown-like beige (BeAT), through the browning process. Considering interest stimulating process disorders lack clarity, evenness, reproducibility preclinical models, detailed description differentiation protocol “ de novo ” development has been described. Furthermore, most described stimuli inducing process, such PPAR-γ agonists (using rosiglitazone, RGZ) β-adrenergic stimulators isoproterenol, ISO), were evaluated order to describe their involvement identify reference compound for induction browning. Methods Immortalized murine embryonic fibroblasts (3T3-L1) differentiated up 17 days using medium (DM) maintenance (MM) without RGZ ISO obtain both phenotype. The was Oil Red O (ORO) staining assay, citrate synthase activity, mitochondrial uncoupling protein 1 (UCP-1) immunodetection expression performed on different (T0, T3, T10, T17) after differentiation. Results results indicated induced morphology ORO-positive deposits increased activity enzyme UCP-1 levels overlapping days. did not display significant effect these experimental conditions. Conclusion Overall, this work describes depth phases offering reproducible model. efficacy stimulation pathway obtaining demonstrates induce elects it perfect procedures field.

Язык: Английский

Процитировано

0

Capsaicin Reduces Obesity by Reducing Chronic Low-Grade Inflammation DOI Open Access

Jiaxin Yang,

Wanyi Li, Yuanwei Wang

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(16), С. 8979 - 8979

Опубликована: Авг. 18, 2024

Chronic low-grade inflammation (CLGI) is associated with obesity and one of its pathogenetic mechanisms. Lipopolysaccharide (LPS), a component Gram-negative bacterial cell walls, the principal cause CLGI. Studies have found that capsaicin significantly reduces relative abundance LPS-producing bacteria. In present study,

Язык: Английский

Процитировано

2

Relationship between Cardiometabolic index and endometriosis in a US nationally representative sample: results from NHANES 1999-2006 DOI Creative Commons

Jiarui Hou,

Wenting Chen,

Rui Wang

и другие.

Frontiers in Endocrinology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 12, 2024

Background Endometriosis is an estrogen-dependent gynecological endocrine condition and a systemic inflammatory disease associated to improper lipid metabolism increased cardiovascular risk. The Cardiometabolic Index (CMI) novel indicator representing visceral adipose tissue distribution metabolic dysfunction, integrating indicators the waist-to-height ratio. While anomalies in are often with (BMI) Body Mass Index, literature consistently shows negative link between endometriosis female BMI, some studies have found that one of few reproductive diseases not persistently positively correlated obesity. Given limitations comprehensive index like CMI crucial for exploring incidence endometriosis. Currently, research on correlation lacking, prompting this study investigate association. Objective To association risk having sample entire U.S. population. Study design A cross-sectional analysis was conducted using data from four cycles National Health Nutrition Examination Survey (NHANES) spanning years 1999 2006. included individuals aged 20 54 documented history complete data. Logistic regression analysis, subgroup interaction analyses, smooth curve fitting, restricted cubic splines (RCS) were utilized examine Results higher had probability developing This relationship remained significant after adjusting potential confounders such as age, ethnicity, Poverty Income Ratio (PIR), drinking, smoking, education level, marital status. fully adjusted model revealed positive (OR = 1.21; 95% CI, 1.04–1.40, p < 0.05). Subgroup analyses showed no effect modification by PIR, hypertension, or menarche age (all p-values > Conclusion Our chance getting endometriosis.Due common occurrence lack clarity surrounding their cause, more needed confirm our results find out if could be used warning sign

Язык: Английский

Процитировано

2